Opioid Agonists and Antagonists

Core Concepts

Opioid receptors: one system, many jobs

Opioid receptors are found throughout the nervous system and gut. The three main types are mu, kappa, and delta, and the mu receptor is the star: it mediates the powerful analgesia, the euphoria, and — dangerously — the respiratory depression and physical dependence. There is no opioid that gives pure pain relief with zero side effects: the receptor that produces the good is the receptor that produces the bad.

The body's own molecules — endorphins, enkephalins, and dynorphins — are the natural ligands, released in response to pain, stress, and some pleasurable activities. They are part of the modulation step of nociception described in Introduction to Pain: they turn the pain signal down at the spinal cord and brain.

Full agonists: maximum effect, maximum risk

Full agonists (prototype: morphine) bind mu receptors and produce the full effect: profound analgesia, plus sedation, euphoria, cough suppression, slowed gut motility (constipation), nausea, urinary retention, itching, pinpoint pupils, and — at sufficient doses — respiratory depression. There is no built-in ceiling to their dangerous effects: as the dose rises, so does the risk of respiratory arrest. This is why they are controlled substances and why every administration is documented and monitored.

Other well-known full agonists (fentanyl, hydromorphone, oxycodone, codeine) share the mu mechanism and differ mainly in potency, speed of onset, duration, and route. Codeine deserves a special note: it is a prodrug — the liver must convert it into its active form (morphine) for it to work, and people differ genetically in how efficiently that happens, so its effect is unpredictable and it can accumulate dangerously in fast converters.

Partial agonists and mixed agonist-antagonists: built-in ceilings

Partial agonists (prototype: buprenorphine) bind the mu receptor but activate it less strongly than full agonists. The practical consequence is a ceiling effect on respiratory depression: beyond a certain dose, the drug stops producing more effect — including more respiratory depression — making these drugs safer in overdose. The same property makes them valuable in opioid use disorder treatment. The trade-off: a partial agonist can displace a full agonist from the receptor, precipitating withdrawal in a person physically dependent on a full agonist.

Mixed agonist-antagonists (e.g., pentazocine and related drugs) act as agonists at some receptors and antagonists at others: analgesia with a ceiling on mu-mediated effects, and the same ability to precipitate withdrawal in dependent people. They are a smaller niche in modern practice but a classic exam topic: "not all opioids are the same."

Antagonists: the reversal agents

Opioid antagonists bind opioid receptors and block them without activating them. Two matter most:

• Naloxone is the emergency reversal agent for opioid overdose. It rapidly displaces the opioid and restores breathing — usually within minutes — but its effect is shorter-lived than many opioids, so the person can slip back into respiratory depression as it wears off. That is why the nurse (and the family, in community settings) stays with the person, monitors, and may need repeat doses per protocol. Giving naloxone to someone physically dependent on opioids can precipitate sudden, severe withdrawal — distressing but not usually life-threatening — and the priority is restoring breathing.
• Naltrexone is a longer-acting antagonist used differently: in recovery from opioid (and alcohol) use disorder, a regular dose blocks the receptors so any opioid taken produces no reward. Because it blocks the receptor completely, it is used only after the person has been off opioids long enough to avoid precipitated withdrawal — a provider-directed plan.

Tolerance, dependence, withdrawal, and addiction

With sustained opioid use, the nervous system adapts. Tolerance means the same dose produces less effect over time, so dose escalation is needed for the same analgesia — and tolerance to analgesia develops faster than tolerance to constipation, which is why constipation persists and must be managed preventively. Physical dependence means the body adapts so stopping abruptly causes withdrawal: anxiety, agitation, muscle aches, sweating, runny nose, abdominal cramping, diarrhea, dilated pupils — very uncomfortable but not typically life-threatening, and managed with a provider-directed taper or medication-assisted approach. Addiction is a chronic brain disease characterized by compulsive use despite harm — not the same as physical dependence, and not a moral failing: many people take opioids daily for pain with dependence but no addiction. Person-first language ("a person with opioid use disorder") and treating addiction as a health condition are professional obligations. The nurse does not diagnose addiction, but screens for signs of misuse or diversion (lost prescriptions, frequent early refill requests, using more than prescribed) and refers concerns to the provider — with compassion, not judgment.

Nursing care and patient teaching

• Baseline assessment: pain score, vital signs (especially respiratory rate and depth), sedation level, and risk factors (age, sleep apnea, lung disease, kidney or liver disease, concurrent CNS depressants) — all increase opioid sensitivity.
• Monitoring after administration: respiratory rate, depth, and sedation on a schedule per facility policy. Increasing sedation often precedes respiratory depression, so "sleepier than before" is a red flag.
• Respiratory depression response: stimulate, call for help, and — per protocol and orders — administer the reversal agent if ordered, then continue monitoring because reversal can wear off.
• Constipation: an expected effect, not a rare side effect; prevention (hydration, fiber, mobility, ordered bowel regimens) is standard care.
• Fall prevention: sedation and orthostatic effects increase fall risk; assist as needed and keep the call light within reach.
• Safe use and stewardship: verify the order, use two identifiers, document per policy, secure storage, never share, and teach about disposal, driving restrictions while sedated, and avoiding alcohol.
• Naloxone education: in many settings, people on opioids are offered naloxone and trained on overdose recognition and response (call emergency services, give naloxone per instructions, stay until help arrives).
• Scope note: what the nurse may administer, monitor, or teach follows state regulations, facility policy, and prescriber orders; no doses, schedules, or administration recommendations are given here — verify against current references, the formulary, and prescriber orders.

Common Confusions